Stockreport

Agios (AGIO) Meets Clinical Proof-of-Concept in Anemia Treatment [Yahoo! Finance]

Agios Pharmaceuticals, Inc.  (AGIO) 
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.agios.com/investor-overview
PDF pyruvate kinase (PK) activator AG-946 to treat anemia in adults with lower-risk myelodysplastic syndromes (MDS). A total of 22 patients were enrolled in this phase IIa [Read more]